ArticlePharmaceuticals (Basel, Switzerland)2022

Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic Patients That Avoided Secukinumab Switching.

Giovanni Damiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.